ArticleRSC advances2022

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics.

Ling-Na Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.